自噬
足细胞
活力测定
免疫印迹
污渍
肾
生物
化学
分子生物学
细胞生物学
细胞
内分泌学
细胞凋亡
生物化学
基因
蛋白尿
作者
Jin‐Ping Wang,Ji‐Ping Yan,Rui‐Ling Xiao,Rong‐Shan Li
摘要
Abstract Leucine‐rich repeat kinase 2 (LRRK2) is a known regulator of autophagy in a range of cell types. Here, we investigated the role of LRRK2‐associated autophagy during acute kidney injury (AKI) and its underlying mechanism(s) of action. Male mice aged 8‐weeks were treated with the LRRK2 inhibitor MLi‐2 and exposed to lipopolysaccharide (LPS) through intraperitoneal injection or ischemia–reperfusion (IR) surgery. Mice were sacrificed 12 or 24 h post‐LPS injection or IR operation and blood was collected for serum creatinine measurements. Kidney cortical tissues were collected for western blot analysis of podocyte‐specific markers and autophagy‐associated proteins. Renal histopathology was observed through hematoxylin‐eosin staining. For cell‐based assays, immortalized mouse podocytes were silenced for LRRK2 through siRNA transfection and exposed to LPS or cobalt chloride. Changes in cell viability were investigated using cell counting kit‐8, flow cytometry and MTT assays. Expression of podocyte‐specific markers and autophagy‐associated proteins were analyzed by western blotting. We observed an increase in LRRK2 expression at 12 h post‐LPS injection and IR surgery that was accompanied by enhanced autophagy. At 24 h post‐treatment, both LRRK2 expression and autophagy declined. Kidney injury was most pronounced in mice treated with MLi‐2. Podocytes silenced for LRRK2 showed a loss of cell viability, decreased levels of podocyte‐specific protein expression and a suppression of autophagy. Together, these data reveal the protective effects of LRRK2 during AKI through enhanced podocyte autophagy and cell viability.
科研通智能强力驱动
Strongly Powered by AbleSci AI